Amferia, a Swedish medtech company, has made significant strides in the fight against antimicrobial resistance. Recently, the company raised €1.2 million to advance its unique hydrogel…
Karius, a leader in infectious disease diagnostics, recently secured $100 million in Series C funding. This marks a significant milestone for the company.The funding is co-led…
Investors are increasingly pushing for a significant reduction in antibiotic use across food supply chains. The urgency stems from widespread concerns over antimicrobial resistance (AMR).Campaigners and…
